Phosphatidylethanolamines (PE)

06:0 PE (PE(6:0/6:0)) is a water-soluble phospholipid characterized by its short acyl chains, exhibiting notable antitumor activity and the ability to inhibit tumor progression in vivo, alongside antiproliferative and proapoptotic effects, while serving as a precursor for phosphatidylcholine and phosphatidylethanolamine.

1-1(Z)-Octadecenyl-2-docosahexaenoyl-sn-glycero-3-PE (18:0p/22:6-PE) is a lipid identified in rat brain tissue by mass spectrometry imaging with specific structural and distribution characteristics, and isomers of different fatty acid chains can be identified by improved methods.

Dipalmitoylphosphatidylethanolamine is a biochemical assay reagent.

Se-DOPE is a phospholipid molecule with selenium. Se-DOPE can be used to synthesize the bifunctional Janus liposozyme. Se-DOPE promotes the production of ROS with induction of lights, scavenges the ROS with the presence of glutathione. Se-DOPE regulates redox and immune homeostasis in infected diabetic wounds.

Acetylhydrolase-IN-1 is a 1-Alkyl-2-acetylglycerophosphocholine esterase (Alkylacetyl-GPC: acetylhydrolase) inhibtor.

C18(Plasm)-18:1 PE is a lycerophospholipid.

DOCP (2-((2,3-Bis(oleoyloxy)propyl)dimethylammonio)ethyl hydrogen phosphate), characterized by their inverted charge orientation compared to traditional phosphocholine (PC) lipids, feature a quaternary amine positioned near the bilayer interface and a phosphate group that protrudes into the aqueous environment. This unique configuration of iPC lipids provides an exceptional opportunity to explore the biophysical properties and bioactivity implications resulting from the charge inversion at the bilayer surface.

2-18:1 Lyso PEis a lysophosphatidylethanolamine.

1-Myristoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine is a lycerophospholipid.

1-1(Z)-Hexadecenyl-2-palmitoyl-sn-glycero-3-PE (compound 18) is a lipid metabolite associated with central nervous system diseases.

Phosphoethanolamine (calcium) (Monoaminoethyl phosphate (calcium); NSC 254167 (calcium); O-Phosphoethanolamine (calcium)) is a precursor to phosphatidylethanolamine and can be used in the synthesis of phosphatidylcholine. Phosphoethanolamine (calcium) is used in the study of phospholipid metabolism and cell membrane structure.

DOPE-N-nonadecanoyl is an ester product.

(S)-1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamine is a phosphatidylethanolamine lipid with palmitoyl fatty acid chains. (S)-1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamine serves as a substrate for glycosylation reactions and a component of biocompatible pH-sensitive hydrophobic copolymer nanoparticles. (S)-1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamine exhibits pH-sensitive drug release properties, enabling faster drug release in acidic environments. (S)-1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamine can be used in studies related to cancer drug delivery.

L-Arg-DSPE is an arginine-functionalized DSPE lipid containing free guanidine groups. L-Arg-DSPE serves as a component of NO-responsive degradable drug-loaded liposomal nanomotors (L-Arg@Lip-DOX), promoting drug deep tumor tissue penetration and cellular internalization. L-Arg-DSPE can be used for the research of drug delivery.

16:0 DNP PE (1,2-Dihexadecanoyl-sn-glycero-3-phosphoethanolamine-N-(2,4-dinitrophenyl) (ammonium)) is a kind of biochemical reagent.

DSPE-pSar20 (DSPE-Polysarcosine20) is a pSar-lipid derivative. DSPE-pSar20 is a hydrophilic alternative to PEG and can be used in drug delivery research.

PEth-16:0/18:1 ammonium is the ammonium salt of a phosphatidylethanol homolog, and it is a phospholipid biomarker reflecting past alcohol consumption. PEth-16:0/18:1 ammonium can be used to determine an individual's past ethanol intake.

16:0-06:0 NBD PE (C6-NBD-PE) is a commonly used fluorescent phospholipid analog and membrane-disrupting agent for investigating membrane lipid structure and dynamics. In aqueous buffers, the self-assembly of 16:0-06:0 NBD PE can be disrupted via binding to methylated α-, β-, and γ-cyclodextrins. 16:0-06:0 NBD PE can be selectively extracted from lipid vesicles upon the addition of methylated cyclodextrins, with an extraction efficiency lower than that of NBD-PC and NBD-SM analogs.

1-Dodecanoyl-sn-glycerophosphoethanolamine, a derivative of phosphatidylethanolamine, interacts with Cinnamycin (HY-P1695) to induce conformational changes. 1-Dodecanoyl-sn-glycerophosphoethanolamine is applicable to studies related to antibiotic synthesis.

LysoPE (20:4/0:0) is a lysophosphatidylethanolamine glycerophospholipid and is an endogenous metabolite.